Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?

  • Gonca KESKİNDEMİRCİ, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Müge GÖKÇE, [MD] [PhD]
  • Deniz TUĞCU, [MD] [PhD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Cengiz BAYRAM, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Sevinç GENÇ, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Gönül AYDOĞAN, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital

Downloads

Download data is not yet available.
Published
2017-11-06
How to Cite
KESKİNDEMİRCİ, G., GÖKÇE, M., TUĞCU, D., BAYRAM, C., GENÇ, S., & AYDOĞAN, G. (2017). Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?. Acta Medica, 46(1), 85-86. Retrieved from https://actamedica.org/index.php/actamedica/article/view/122
Section
Letters to the Editor/Technical Note